An ex vivo experiment using the demethylating agent Decitabine (5-aza-2 -deoxycytidine) was shown to induce MCT3 expression in a dose dependant manner, as all hypermethylated sites in the exon 2 CpG island became demethylated after treatment.
Un experimento ex vivo utilizando o axente desmetilante decitabina (5-aza-2 -desoxicitidina) induciu a expresión de MCT3 de maneira dependente da dose, porque todos os sitios hipermetilados na illa CpG do exón 2 quedaron desmetilados despois do tratamento.